Apellis Pharmaceuticals, Inc. (APLS)
NASDAQ: APLS · Real-Time Price · USD
24.97
-0.19 (-0.76%)
At close: Dec 26, 2025, 4:00 PM EST
24.82
-0.15 (-0.60%)
After-hours: Dec 26, 2025, 5:00 PM EST
Apellis Pharmaceuticals Analyst Ratings
Total Analysts
20
Consensus Rating
Buy
Price Target
$33.89
Upside
+35.72%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel | Stifel | Strong Buy Maintains $55 → $48 | Strong Buy | Maintains | $55 → $48 | +92.23% | Dec 19, 2025 |
| Wolfe Research | Wolfe Research | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Nov 6, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $40 → $36 | Buy | Maintains | $40 → $36 | +44.17% | Nov 5, 2025 |
| Mizuho | Mizuho | Hold Maintains $24 → $19 | Hold | Maintains | $24 → $19 | -23.91% | Nov 3, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $52 → $45 | Strong Buy | Maintains | $52 → $45 | +80.22% | Oct 31, 2025 |
| TD Cowen | TD Cowen | Strong Buy Maintains $50 → $45 | Strong Buy | Maintains | $50 → $45 | +80.22% | Oct 31, 2025 |
| Baird | Baird | Buy Maintains $50 → $52 | Buy | Maintains | $50 → $52 | +108.25% | Oct 31, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $57 → $45 | Strong Buy | Maintains | $57 → $45 | +80.22% | Oct 31, 2025 |
| B of A Securities | B of A Securities | Hold Maintains $26 → $29 | Hold | Maintains | $26 → $29 | +16.14% | Oct 20, 2025 |
| Wells Fargo | Wells Fargo | Hold → Buy Upgrades $29 → $32 | Hold → Buy | Upgrades | $29 → $32 | +28.15% | Oct 15, 2025 |
| Goldman Sachs | Goldman Sachs | Hold → Strong Sell Downgrades $26 → $18 | Hold → Strong Sell | Downgrades | $26 → $18 | -27.91% | Sep 26, 2025 |
| Mizuho | Mizuho | Hold Maintains $21 → $22 | Hold | Maintains | $21 → $22 | -11.89% | Aug 4, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $35 → $37 | Buy | Maintains | $35 → $37 | +48.18% | Aug 4, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $46 → $52 | Strong Buy | Maintains | $46 → $52 | +108.25% | Aug 1, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $17 → $19 | Hold | Maintains | $17 → $19 | -23.91% | Aug 1, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $39 → $40 | Buy | Maintains | $39 → $40 | +60.19% | Aug 1, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.